American Bio Medica Corporation (ABMC)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST
American Bio Medica Statistics
Total Valuation
American Bio Medica has a market cap or net worth of 48.
| Market Cap | 48 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
American Bio Medica has 48.10 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 48.10M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 0.00.
| PE Ratio | 0.00 |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.59
| Current Ratio | 0.59 |
| Quick Ratio | 0.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.26 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -68.18% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 36,300 |
| Profits Per Employee | 42,500 |
| Employee Count | 20 |
| Asset Turnover | 0.65 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 28.37 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 29.08 |
| Average Volume (20 Days) | 1,252 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, American Bio Medica had revenue of 726,000 and earned 850,000 in profits. Earnings per share was 0.02.
| Revenue | 726,000 |
| Gross Profit | -147,000 |
| Operating Income | -1.21M |
| Pretax Income | 852,000 |
| Net Income | 850,000 |
| EBITDA | -1.17M |
| EBIT | -1.21M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 68,000 in cash and 175,000 in debt, giving a net cash position of -107,000 or -0.00 per share.
| Cash & Cash Equivalents | 68,000 |
| Total Debt | 175,000 |
| Net Cash | -107,000 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -458,000 |
| Book Value Per Share | -0.01 |
| Working Capital | -458,000 |
Cash Flow
| Operating Cash Flow | -1.12M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -20.25%, with operating and profit margins of -167.08% and 117.08%.
| Gross Margin | -20.25% |
| Operating Margin | -167.08% |
| Pretax Margin | 117.36% |
| Profit Margin | 117.08% |
| EBITDA Margin | -160.74% |
| EBIT Margin | -167.08% |
| FCF Margin | n/a |
Dividends & Yields
American Bio Medica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.91% |
| Shareholder Yield | -6.91% |
| Earnings Yield | 1,770,833.33% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
American Bio Medica has an Altman Z-Score of -54.91. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -54.91 |
| Piotroski F-Score | n/a |